Literature DB >> 30362837

Analysis of the Outcomes of Combined Cross-Linking with Intracorneal Ring Segment Implantation for the Treatment of Pediatric Keratoconus.

Mohammed Iqbal1, Ahmed Elmassry2, Ahmed Tawfik3, Waleed Abou Samra4, Mervat Elgharieb5, Hosam Elzembely6, Ashraf Soliman7, Hisham Saad8, Islam El Saman1, Ahmed Saeed9, Mahmoud Farouk1, Tarek Tawfik9, Amin Abou Ali1, Omar Fawzy10.   

Abstract

PURPOSE: To analyze the visual and refractive outcomes of combined accelerated cross-linking with femtosecond laser intracorneal ring segment implantation for the treatment of pediatric keratoconus.
MATERIALS AND METHODS: This retrospective multicenter noncomparative clinical study included 63 eyes of 37 patients (age, 9-17 years) who underwent between August and September 2016 combined cross-linking with intracorneal ring segment implantation for keratoconus. Preoperative and postoperative (6, 12, and 18 months) uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), subjective refractions, keratometry (K), and pachymetry measurements were compared.
RESULTS: The postoperative spherical equivalent refraction was within ±1 D, ±2 D, and ±3 D in 19 (30.2%), 27 (42.9%), and 37 (58.8%) eyes, respectively. Only 27 eyes achieved the attempted preoperative spherical equivalent refraction. The mean spherical equivalent refraction significantly improved from -6.01 ± 2.97 to -3.13 ± 2.78 D postoperatively (P < 0.0001). The mean K average reading significantly decreased from 48.75 ± 4.25 to 46.65 ± 3.89 D postoperatively (P < 0.0001). The mean postoperative myopic, astigmatic, and spherical equivalent corrections were -2.17 ± 2.19, -1.52 ± 2.03, and -2.93 ± 2.35 D, respectively. The mean UDVA and CDVA showed significant improvements (0.89 ± 0.33 to 0.40 ± 0.28, P < 0.0001; 0.35 ± 0.31 to 0.25 ± 0.24, P = 0.004; respectively) at 18 months postoperatively. Keratoconus progression, segment migration, and segment extrusion were seen in four (6.4%), one (1.6%), and three (4.7%) eyes, respectively, probably contributing to the lower mean postoperative CDVA.
CONCLUSION: Cross-linking plus is only partially effective for pediatric keratoconus. Despite some improvements in vision and keratometry measures, it resulted in complications such as keratoconus progression, segment extrusion, and segment migration that affected the vision in some patients. These findings suggest an assessment of standard epithelium-off collagen cross-linking as a sole procedure to treat pediatric keratoconus in future studies.

Entities:  

Keywords:  Pediatric keratoconus; cross-linking; cross-linking plus; intracorneal ring segments; keratoconus

Mesh:

Substances:

Year:  2018        PMID: 30362837     DOI: 10.1080/02713683.2018.1540706

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  4 in total

1.  Outcomes of different lines of keratoconus management in a tertiary eye center in north China.

Authors:  Jing Zhang; Xian-Li Du; Lei Wan; Yan-Ling Dong; Li-Xin Xie
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

2.  Visual and Refractive Long-Term Outcomes Following Standard Cross-Linking in Progressive Keratoconus Management.

Authors:  Mohammed Iqbal; Ahmed Elmassry; Amani E Badawi; Hesham M Gharieb; Omar M Said
Journal:  Clin Ophthalmol       Date:  2019-12-12

3.  Diagnosis of keratoconus in a young male by electrophysiological test findings: A case report.

Authors:  Weiming Yan; Yanjin Chen; Xiaohong Chen; Qian Ye; Yutong Wang; Chuan Jiang; Xiangrong Zheng; Yunpeng Wang; Meizhu Chen
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

4.  Standard cross-linking protocol versus accelerated and transepithelial cross-linking protocols for treatment of paediatric keratoconus: a 2-year comparative study.

Authors:  Mohammed Iqbal; Ahmed Elmassry; Hisham Saad; Ahmed Am Gad; Ola Ibrahim; Noha Hamed; Ahmed Saeed; Ahmad S Khalil; Mohamed Tawfik; Amr Said; Ibrahim Amer; Asaad Nooreldin; Omar Said; Mohamed Reffat; Seif Anwar; Amani Badawi
Journal:  Acta Ophthalmol       Date:  2019-10-25       Impact factor: 3.761

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.